33776892|t|Anti-aquaporin 4 IgG Is Not Associated With Any Clinical Disease Characteristics in Neuromyelitis Optica Spectrum Disorder.
33776892|a|Background: Neuromyelitis optica spectrum disorder (NMOSD) is a clinically defined, inflammatory central nervous system (CNS) disease of unknown cause, associated with humoral autoimmune findings such as anti-aquaporin 4 (AQP4)-IgG. Recent clinical trials showed a benefit of anti-B cell and anti-complement-antibodies in NMOSD, suggesting relevance of anti-AQP4-IgG in disease pathogenesis. Objective: AQP4-IgG in NMOSD is clearly defined, yet up to 40% of the patients are negative for AQP4-IgG. This may indicate that AQP4-IgG is not disease-driving in NMOSD or defines a distinct patient endotype. Methods: We established a biobank of 63 clinically well-characterized NMOSD patients with an extensive annotation of 351 symptoms, patient characteristics, laboratory results and clinical scores. We used phylogenetic clustering, heatmaps, principal component and longitudinal causal interference analyses to test for the relevance of anti-AQP4-IgG. Results: Anti-AQP4-IgG was undetectable in 29 (46%) of the 63 NMOSD patients. Within anti-AQP4-IgG-positive patients, anti-AQP4-IgG titers did not correlate with clinical disease activity. Comparing anti-AQP4-IgG-positive vs. -negative patients did not delineate any clinically defined subgroup. However, anti-AQP4-IgG positive patients had a significantly (p = 0.022) higher rate of additional autoimmune diagnoses. Conclusion: Our results challenge the assumption that anti-AQP4-IgG alone plays a disease-driving role in NMOSD. Anti-AQP4-IgG might represent an epiphenomenon associated with NMOSD, may represent one of several immune mechanisms that collectively contribute to the pathogenesis of this disease or indeed, anti-AQP4-IgG might be the relevant factor in only a subgroup of patients.
33776892	5	16	aquaporin 4	Gene	361
33776892	84	122	Neuromyelitis Optica Spectrum Disorder	Disease	MESH:D009471
33776892	136	174	Neuromyelitis optica spectrum disorder	Disease	MESH:D009471
33776892	176	181	NMOSD	Disease	MESH:D009471
33776892	208	257	inflammatory central nervous system (CNS) disease	Disease	MESH:D002493
33776892	300	310	autoimmune	Disease	MESH:D001327
33776892	333	344	aquaporin 4	Gene	361
33776892	346	350	AQP4	Gene	361
33776892	446	451	NMOSD	Disease	MESH:D009471
33776892	482	486	AQP4	Gene	361
33776892	527	531	AQP4	Gene	361
33776892	539	544	NMOSD	Disease	MESH:D009471
33776892	586	594	patients	Species	9606
33776892	612	616	AQP4	Gene	361
33776892	645	649	AQP4	Gene	361
33776892	680	685	NMOSD	Disease	MESH:D009471
33776892	708	715	patient	Species	9606
33776892	796	801	NMOSD	Disease	MESH:D009471
33776892	802	810	patients	Species	9606
33776892	857	864	patient	Species	9606
33776892	1065	1069	AQP4	Gene	361
33776892	1089	1093	AQP4	Gene	361
33776892	1137	1142	NMOSD	Disease	MESH:D009471
33776892	1143	1151	patients	Species	9606
33776892	1165	1169	AQP4	Gene	361
33776892	1183	1191	patients	Species	9606
33776892	1198	1202	AQP4	Gene	361
33776892	1279	1283	AQP4	Gene	361
33776892	1311	1319	patients	Species	9606
33776892	1385	1389	AQP4	Gene	361
33776892	1403	1411	patients	Species	9606
33776892	1470	1480	autoimmune	Disease	MESH:D001327
33776892	1551	1555	AQP4	Gene	361
33776892	1598	1603	NMOSD	Disease	MESH:D009471
33776892	1610	1614	AQP4	Gene	361
33776892	1668	1673	NMOSD	Disease	MESH:D009471
33776892	1803	1807	AQP4	Gene	361
33776892	1863	1871	patients	Species	9606
33776892	Association	MESH:D009471	361

